Education

Critical Care Residency (PGY2)

The Critical Care Team was established in 2000 jointly within the Departments of Hospital Pharmacy Services and Pharmacy Practice. Members of this team are responsible for direct patient care of critically ill patients hospitalized at the University of Illinois Medical Center at Chicago in a variety of specialty areas. Many of these individuals have innovative practice sites with collaborative prescribing agreements with their physician colleagues. Each member is actively involved in medical center, quality improvement, and departmental committees. In addition to patient care responsibilities, team members are also responsible for experiential training of pharmacy students and pharmacy residents, didactic teaching, research, and other scholarly activities related to their specialty areas. Lastly, in 2000, this group established a postdoctoral specialty residency in Critical Care, receiving ASHP accreditation in 2004.

Faculty

Jeffrey J. Mucksavage, PharmD, BCPS - Team Leader
Clinical Assistant Professor
Clinical Pharmacist, Neurosciences

Eljim P. Tesoro, PharmD, BCPS
Clinical Associate Professor
Clinical Pharmacist, Neurosciences
Director, PGY2 Critical Care Pharmacy Residency

Robert J. DiDomenico, PharmD
Clinical Associate Professor
Clinical Pharmacist, Cardiology and Cardiothoracic Surgery
Director, PGY2 Cardiology Residency

Julie Golembiewski, PharmD
Clinical Associate Professor
Clinical Pharmacist, OR/Anesthesiolog

Alan Gross, PharmD
Clinical Assistant Professor
Clinical Pharmacist, Infectious Diseases

Michael T. Johnson, PharmD
Clinical Assistant Professor
Clinical Pharmacist, Medical/Surgical ICU

Keri Kim, PharmD, MS CTS, BCPS
Clinical Assistant Professor
Clinical Pharmacist, Neurosciences

Frank Paloucek, PharmD, DABAT
Clinical Associate Professor
Clinical Pharmacist, Toxicology
Director, PGY1 Pharmacy Residency 

Renee Petzel-Gimbar, PharmD
Clinical Assistant Professor
Clinical Pharmacist, Emergency Medicine
Director, PGY2 Emergency Medicine Residency

Renee Xamplas, PharmD, BCPS
Adjunct Clinical Assistant Professor
Clinical Pharmacist, Medical ICU - John H. Stroger, Jr. Hospital of Cook County

Natasa Stevkovic, PharmD, BCPS
Adjunct Clinical Assistant Professor
Clinical Pharmacist, Trauma ICU/Burn ICU - John H. Stroger, Jr. Hospital of Cook County

Shellee Grim, PharmD, BCPS
Clinical Assistant Professor
Clinical Pharmacist, Infectious Diseases - Loyola University Medical Center

Specialty Residency in Critical Care (PGY2) links

Current/ Past Residents in Critical Care (PGY2)

2000 – 2001 Allison Schreiver (Einhorn), PharmD
2001 – 2002 Jeffrey J. Mucksavage, PharmD, BCPS
2002 – 2003 Rosa Yeh, PharmD, BCPS
2003 – 2004 Renee Xamplas (Costianis), PharmD, BCPS 
2004 – 2005 Kimberly Levasseur-Franklin, PharmD, BCPS 
2005 – 2006 Marcia Curran (Hunt), PharmD, BCPS 
2006 – 2007 Jaclyn Litynsky (Sauve), PharmD, BCPS
2007 – 2008 Jerusha E. Taylor, PharmD, BCPS
2008 – 2009 Elena Santayana, PharmD, BCPS 
2009 – 2010 Scott T. Benken, Pharm D, BCPS
2010 – 2011 Karen Berger, Pharm D, BCPS
2011 – 2012 Sean P. Kane, PharmD, BCPS
2012 – 2013 Katherine Jennings, PharmD
2013 – 2014 Amanda Cantin, PharmD
2014 – 2015 Laura Means, PharmD

Recent Publications:

  1. Jarrett O, Grim SA, Benedetti E, Clark NM. Gastrointestinal tuberculosis in renal transplant recipients: case report and review of the literature. Transpl Infect Dis 2010 Jul 6. [Epub ahead of print]
  2. Tesoro EP, Brophy GM. Pharmacological management of seizures and status epilepticus in critically ill patients. Journal of Pharmacy Practice 2010;23(5):441-454.
  3. Panos NG, Tesoro EP, Kim KS, Mucksavage JJ. Outcomes associated with transdermal nicotine replacement therapy in a neurosurgery intensive care unit. Am J Health Syst Pharm 2010 Aug 15;67(16):1357-61.
  4. Grim SA, Pereira E, Guzman G, Clark NM. CMV PCR as a diagnostic tool for CMV gastrointestinal disease after solid organ transplantation. Transplantation 2010 Oct 15;90(7):799-801.
  5. Golembiewski J, Rakic AM. Opioids. J Perianesth Nurs 2010 Aug;25(4):258-60.
  6. Golembiewski J. Economic considerations in the use of inhaled anesthetic agents. Am J Health Syst Pharm 2010 Apr 15;67(8 Suppl 4):S9-12.
  7. Bickham P, Golembiewski J. Contrast media use in the operating room. J Perianesth Nurs 2010 Apr;25(2):94-103.
  8. Reid GE, Grim SA, Sankary H, Benedetti E, Oberholzer J, Clark NM. Early intra-abdominal infections associated with orthotopic liver transplantation. Transplantation 2009 Jun 15;87(11):1706-11.
  9. Walsh RC, Felice KL, Meehan TJ, Stull BW, Schumann HM, Zautcke JL. Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia. Am J Emerg Med 2009 Sep;27(7):901.e1-2.
  10. Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V, Campbell-Lee SA, Tzvetanov IG, Sankary HN, Kaplan B, Benedetti E, Oberholzer J. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Transplantation 2009 Jan 27;87(2):268-73.
  11. Golembiewski J. Surgical antibiotic prophylaxis--focus on dosing. J Perianesth Nurs 2009 Dec;24(6):406-8.
  12. Rakic AM, Golembiewski J. Low-dose ketamine infusion for postoperative pain management. J Perianesth Nurs 2009 Aug;24(4):254-7
  13. Ipema HJ, Golembiewski J. Peripheral opioid receptor antagonists for postoperative bowel dysfunction. J Perianesth Nurs 2009 Apr;24(2):128-30.
  14. Campara M, West-Thielke P, Thielke J, Ommert T, Oberholzer J, Benedetti E, Kaplan B. ABO incompatible renal transplantation in an HIV-seropositive patient. Transplantation 2008 Jul 15;86(1):176-8.
  15. West-Thielke P, Herren H, Thielke J, Oberholzer J, Sankary H, Raofi V, Benedetti E, Kaplan B. Results of positive cross-match transplantation in African American renal transplant recipients. Am J Transplant 2008 Feb;8(2):348-54.
  16. Panos NG, Tesoro EP, Kim KS, Mucksavage JJ.  Outcomes associated with transdermal nicotine replacement therapy in a neurosurgery intensive care unit.  American Journal of Health-System Pharmacy.  (In Press).

  17. Grim SA, Clark NM.  The role of adjuvant agents in treating fungal diseases.  Curr Fungal Infect Reports 2009;3(2):117-26. 

  18. Reid GE, Grim SA, Sankary H, Benedetti E, Oberholzer J, Clark NM.  Early intraabdominal infections associated with orthotopic liver transplantation.  Transplantation 2009;87(11):1706-11.

  19. Grim SA, Hong I, Freeman J, Edwards C, Clark NM.  Daptomycin for the treatment of vancomycin-resistant enterococcal infections.  J Antimicrob Chemother 2009;63(2):414-6.

  20. Donnelly AJ, Golembiewski JA. Perioperative Care. In: Koda-Kimble MA, Young LY, Alldredge BK et. al. (eds) Applied Therapeutics:  The Clinical Use of Drugs. 9th edition. Lippincott Williams & Wilkins, <?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Philadelphia, PA. 2009. pp. 9-1 to 9-36.

  21. Kim KS, Brophy GM.  Symptomatic Venous Thromboembolism Incidence and Risk Factors in Patients with Spontaneous or Traumatic Intracranial Hemorrhage.  Neurocritical Care 2009;11:28-33.

  22. Acute Postoperative Pain, Chronic Pain Management, Moderate Sedation, and Postoperative Nausea and Vomiting sections.  In Donnelly AJ, Baughman VL, Gonzales JP, Golembiewski J, Tomsik EA. Anesthesiology & Critical Care Drug Handbook, Lexi-Comp, 8th edition, 2008-2009. 

  23. Grim SA, Rene L, Gupta S, Clark NM.  Safety of linezolid in patients with baseline thrombocytopenia.  J Antimicrob Chemother 2008;62:4:850-1.

  24. Didomenico RJ, Perez A, Schumann HM, Fontana DR, Kondos GT, Schumock GT. Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure. Ann Pharmacother. 2008 Mar;42(3):327-33.

  25. Alhyraba M, Grim SA, Benedetti E, Clark NM.  Unusual presentation of cytomegalovirus enteritis after liver and kidney transplantation.  Transplant Infect Dis 2007;9:343-6.

  26. Grim SA, Pham T, Thielke J, Sankary H, Oberholzer J, Benedetti E, Clark NM.  Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients.  Clin Transplant 2007;21(5):628-32. 

  27. Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM.  Rapid development of tigecycline resistance in Acinetobacter baumannii.  Pharmacotherapy 2007;27(8):1198-201.

  28. Kim KS, Brophy GM.  Venous Thromboembolism Incidence and Risk Factors in Neurosurgical Intensive Care Unit Patients Receiving Pharmacological and Mechanical Prophylaxis.  Pharmacotherapy 2006;26(5):734.  Abstract

  29. Wagner DS, Golembiewski J. Meds on the move: from cupboard to machine. J Perianesth Nurs 2005;20(6):444-6.

  30. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, Mucksavage J, Tesoro E. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery 2005;57(5):832-6; discussion -6.

  31. Golembiewski J , Torrecer S, Katke J. The use of opioids in the postoperative setting: focus on morphine, hydromorphone, and fentanyl. J Perianesth Nurs 2005;20(2):141-3.

  32. Golembiewski J , Chernin E, Chopra T. Prevention and treatment of postoperative nausea and vomiting. Am J Health Syst Pharm 2005;62(12):1247-60; quiz 61-2.

  33. Golembiewski J . Dexmedetomidine--does it have a role in the perioperative setting? J Perianesth Nurs 2005;20(4):289-91.

  34. Golembiewski J , Chernin E, Chopra T. Availability of different dosage forms of scopolamine. Am J Health Syst Pharm 2005;62(22):2350-2.

  35. Galanter WL, Didomenico RJ, Polikaitis A. A trial of automated decision support alerts for contraindicated medications using computerized physician order entry. J Am Med Inform Assoc 2005;12(3):269-74.

  36. DiDomenico RJ , Massad MG. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg 2005;79(2):728-40.

  37. DiDomenico RJ , Massad MG, Kpodonu J, Navarro RA, Geha AS. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass. Chest 2005;127(5):1828-35.

  38. Grim SA , Rapp RP, Martin CA, Evans ME.  Trimethoprim/sulfamethoxazole: Is this a viable agent for the treatment of infections caused by methicillin-resistant Staphylococcus aureus?  Pharmacotherapy 2005;25(2):253-64.

  39. Miles MV, Tang PH, Ryan MA, Grim SA, Fakhoury TA, Strawsburg RH, deGrauw TJ, Baumann RJ.  Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).  Ther Drug Monitor 2004;26(3):300-4. 

  40. Stevenson JG, Pearlman M, Green CR, Newland S, Grondin L, Thompson M, Golembiewski J, Campbell D. Altering meperidine prescribing patterns in a university teaching hospital. Jt Comm J Qual Saf 2004;30(5):277-81, 33.

  41. Slavin KV, Tesoro EP, Mucksavage JJ. The treatment of cancer pain. Drugs Today (Barc) 2004;40(3):235-45.

  42. Mancuso CE, Paloucek FP. Understanding and preparing for pharmacy practice residency interviews. Am J Health Syst Pharm 2004;61(16):1686-9.

  43. Kuchta A, Golembiewski J. Medication use in the elderly patient: focus on the perioperative/perianesthesia setting. J Perianesth Nurs 2004;19(6):415-24; quiz 25-7.

  44. Golembiewski JA . Antibiotic prophylaxis for preventing surgical site infection. J Perianesth Nurs 2004;19(2):111-3.

  45. Golembiewski J . Inhaled anesthetics and the role of the pharmacist in today's surgical environment. Introduction. Am J Health Syst Pharm 2004;61 Suppl 4:S2-3.

  46. Golembiewski J . Considerations in selecting an inhaled anesthetic agent: case studies. Am J Health Syst Pharm 2004;61 Suppl 4:S10-7.

  47. Galanter WL, Polikaitis A, DiDomenico RJ. A trial of automated safety alerts for inpatient digoxin use with computerized physician order entry. J Am Med Inform Assoc 2004;11(4):270-7.

  48. Eckhoff CD, Didomenico RJ, Shapiro NL. Initiating warfarin therapy: 5 mg versus 10 mg. Ann Pharmacother 2004;38(12):2115-21.

  49. DiDomenico RJ , Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother 2004;38(4):649-60.

  50. DiDomenico RJ . Randomized trial of warfarin nomograms. Ann Intern Med 2004;140(6):489-90; author reply 91-2.

  51. DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother. 2004 Apr;38(4):649-60.